WebFierce Pharma covers the pharma waterfront, from late-stage drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, … WebJan 11, 2024 · By acquiring MYND Group, Fingerpaint has continued its takeover spree and added to the capabilities of its recently rebranded market access group. Nick Paul Taylor …
Welcome to Ipsen US
WebIpsen est un groupe biopharmaceutique français fondé en 1929, spécialisé en oncologie, en neurosciences, dans les maladies rares [1] ... En janvier 2024, Ipsen annonce l'acquisition de certains actifs de Merrimack Pharmaceuticals, notamment Onivyde, destiné au traitement du cancer du pancréas et de l'ovaire, pour 1 milliard de dollars [14]. WebNov 5, 2024 · Now, it’s losing Howard Mayer, M.D., Shire’s ex-senior vice president, chief medical officer and head of R&D at its neuroscience unit. He moves over to French biotech Ipsen as its new EVP and ... ecowater refiner boost
Ipsen
WebJan 18, 2024 · (Ipsen via Twitter) With its recent $952 million deal for Albireo, Ipsen joined a growing list of biopharma companies doubling … WebPhone Number (331) 583-3500. Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care. Ipsen develops and commercializes innovative medicines in three key … WebInspiring hope, improving patients' lives. We are a global biopharmaceutical leader dedicated to improving lives through innovative medicines in oncology, neuroscience, and rare disease. Get to know us Careers. ecowater replacement